| Name | Title | Contact Details |
|---|
Midtex Mapping Services Co is a Red Oak, TX-based company in the Business Services sector.
Harnham is a global recruitment company specializing in the Data & Analytics market, established in 2006. With offices in key locations such as London, New York, San Francisco, Phoenix, and Berlin, Harnham has become a leading authority in data and AI talent acquisition. The company offers recruitment services for both permanent and contract roles, catering to a diverse range of organizations from startups to multinational corporations. Harnham provides specialized consultancy focused on data and AI talent, helping organizations enhance their data capabilities. Their expertise covers all levels of seniority and technical skills within the data, analytics, and AI sectors. The company is also committed to corporate social responsibility, engaging in community programs that support local food banks, homeless charities, and other social causes across the UK, US, and Germany. Recently, Harnham expanded its presence in the US with a new office in Tempe, Arizona, to meet the growing demand for data and analytics talent.
Palm Restaurant is a New York, NY-based company in the Business Services sector.
Independent Purchasing Cooperative
InnoCare Pharma is a commercial stage biopharmaceutical company dedicated to discovering, developing, and commercializing best-in-class and/or first-in-class drugs for the treatment of cancer and autoimmune diseases. InnoCare has strong in-house innovation capabilities, holding multiple foreign and domestic patents with a rich product pipeline target liquid tumors, solid tumors, and autoimmune diseases. Our team has discovered and developed a strong pipeline. InnoCare was co-founded by Professor Shi Yigong, a world-renowned structural biologist, and Dr. Cui Jisong, an outstanding leader in the biopharmaceutical industry. We have over 1000 employees. Our core R&D staff brings rich experience from the worlds top pharmaceutical companies, such as Pfizer, GSK, Bristol-Myers Squibb, Merck, Johnson & Johnson, Bayer, etc. We are a truly global biopharmaceutical company with sites in Beijing, Nanjing, Shanghai, and Guangzhou, Hong Kong and Unites States. On March 23, 2020, InnoCare officially listed on the Hong Kong Stock Exchange (code: 9969). And on Sept. 21, 2023, InnoCare successfully got listed on STAR Board of Shanghai Stock Exchange (code: 688428). Our vision is to become a world-class biopharma leader to address the unmet medical needs globally.